Tofersen API Manufacturers
compare suppliers & get competitive offers
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Tofersen is listed?
Join our notification list by following this page.
Join our notification list by following this page.
List your company
Are you a supplier of Tofersen or other APIs and are you looking to list your company on Pharmaoffer?
Click the button below to find out more
Click the button below to find out more
Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?
Click the button below to switch over to the contract services area of Pharmaoffer.
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Tofersen API 2088232-70-4?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Tofersen. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Tofersen
- Synonyms:
- Antisense Oligonucleotide Inhibitor Of The Expression Of Superoxide Dismutase 1 Gene , DNA, D((2'-O-(2-METHOXYETHYL))M5RC-SP-(2'-O-(2-METHOXYETHYL))RA-(2'-O-(2-METHOXYETHYL))RG-SP-(2'-O-(2-METHOXYETHYL))RG-(2'-O-(2-METHOXYETHYL))RA-SP-T-SP-A-SP-M5C-SP-A-SP-T-SP-T-SP-T-SP-M5C-SP-T-SP-A-SP-(2'-O-(2-METHOXYETHYL))M5RC-(2'-O-(2-METHOXYETHYL))R , IONIS SOD1Rx , Tofersen
- Cas Number:
- 2088232-70-4
- DrugBank number:
- DB14782
- Unique Ingredient Identifier:
- 2NU6F9601K
General Description:
Tofersen, identified by CAS number 2088232-70-4, is a notable compound with significant therapeutic applications. Tofersen is under investigation in clinical trial NCT03764488 (A Study to Evaluate Safety, Tolerability, and Distribution of a Microdose of Radiolabeled BIIB067 (99mTc-MAG3-BIIB067) Co-administered With BIIB067 to Healthy Adults).
Categories:
Tofersen is categorized under the following therapeutic classes: Nucleic Acids, Nucleotides, and Nucleosides, Nucleotides, Polynucleotides. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
